Series B funding round for Edgewise Therapeutics raising $50M in September 2019
Series B funding round for Edgewise Therapeutics raising $50M in September 2019
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
Novo VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Robert Garland | |
| Angel | Carol Gallagher |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$145M
Top Valuation
-
Edgewise Therapeutics raised $50M in a Series B round.
The round was announced on 09/01/19.
The round was led by U.S. Venture Partners, Ken Harrison.